title: Recent advances in the management of gallstones.
abstract: Demands for less invasive, more cost-effective therapy have revolutionized the management of gallstones over the past 10 years. There are no reliable methods of permanently reversing the pathophysiologic defects that cause gallstones. Open cholecystectomy (OC), the gold standard for managing symptomatic cholelithiasis, has been largely replaced by laparoscopic cholecystectomy (LC), which has the advantages of a minimal hospital stay and quicker return to work. Other adjunctive therapies, limited in applicability to selected patients, include oral bile acid therapy (BAT), dissolutional agents, and extracorporeal shock wave lithotripsy. Choledocholithiasis (CDL), formerly managed exclusively with surgical common duct exploration, is increasingly treated with therapeutic biliary endoscopy. Methods of laparoscopic common bile duct exploration are being developed. Optimal algorithms for applying these techniques to patients undergoing LC are evolving. In a sense, the solution to all, or certainly most, gallstones now can be seen through a scope.
authors.affiliation: Department of Medicine, Louisiana State University School of Medicine, Shreveport 71130.
authors.forename: C F
authors.initials: CF
authors.lastname: Gholson
authors.forename: K
authors.initials: K
authors.lastname: Sittig
authors.forename: J C
authors.initials: JC
authors.lastname: McDonald
mesh_terms: D001647:Bile Acids and Salts / Q000627:therapeutic use*; D002760:Cholangiopancreatography, Endoscopic Retrograde; D002763:Cholecystectomy / Q000009:adverse effects; D017081:Cholecystectomy, Laparoscopic; D002769:Cholelithiasis / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D005260:Female; D042882:Gallstones / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D008096:Lithotripsy; D008297:Male
chemical_list: D001647:Bile Acids and Salts